ANI Pharmaceuticals Inc [ANIP] stock prices are down -2.81% to $87.47 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ANIP shares have gain 7.35% over the last week, with a monthly amount glided 28.56%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on July 10, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $84. Previously, Jefferies started tracking the stock with Buy rating on March 14, 2025, and set its price target to $80. On March 12, 2025, JP Morgan initiated with a Overweight rating and assigned a price target of $85 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $80 on December 11, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $68 as its price target on October 11, 2024. CapitalOne started tracking with a Overweight rating for this stock on March 15, 2024, and assigned it a price target of $80. In a note dated August 22, 2023, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $60 to $73.
The stock price of ANI Pharmaceuticals Inc [ANIP] has been fluctuating between $52.50 and $90.23 over the past year. Currently, Wall Street analysts expect the stock to reach $90 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $87.47 at the most recent close of the market. An investor can expect a potential return of 2.89% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
The ANI Pharmaceuticals Inc [NASDAQ:ANIP] reported sales of 747.40M for trailing twelve months, representing a surge of 53.12%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.03 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.23 points at the first support level, and at 82.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 89.93, and for the 2nd resistance point, it is at 92.38.
Ratios To Look Out For
It’s worth pointing out that ANI Pharmaceuticals Inc [NASDAQ:ANIP]’s Current Ratio is 2.54. Also, the Quick Ratio is 1.96, while the Cash Ratio stands at 0.92. Considering the valuation of this stock, the price to sales ratio is 2.54, the price to book ratio is 4.35.
Transactions by insiders
Recent insider trading involved PATRICK WALSH, Director, that happened on Aug 15 ’25 when 9000.0 shares were purchased. Director, AMPERSAND 2020 LIMITED PARTNER completed a deal on Aug 15 ’25 to buy 91000.0 shares. Meanwhile, Officer Shanmugam Muthusamy bought 52990.0 shares on Aug 15 ’25.
